Sergio Traversa - Dec 15, 2023 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Chief Executive Officer, Director
Signature
/s/ Sergio Traversa
Stock symbol
RLMD
Transactions as of
Dec 15, 2023
Transactions value $
$0
Form type
4
Date filed
12/19/2023, 05:28 PM
Previous filing
May 30, 2023
Next filing
Jan 31, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Award $0 +184K $0.00 184K Dec 15, 2023 Common Stock 184K $2.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in 16 equal quarterly installments commencing on March 15, 2024.